Reply

[...]the authors attract attention to the results of the ISAR-TRIPLE (Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting) trial (p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-02, Vol.65 (5), p.516
Main Authors: Dewilde, Willem JM, Janssen, Paul WA, Verheugt, Freek WA, Storey, Robert F, Adriaenssens, Tom, Hansen, Morten L, Lamberts, Morten, ten Berg, Jurriën M
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Anticoagulants
Aspirin
Cardiac arrhythmia
Cardiology
Drug therapy
Heart attacks
Thrombosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]the authors attract attention to the results of the ISAR-TRIPLE (Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting) trial (presented at Transcatheter Cardiovascular Therapeutics, September 2014, Washington, DC). [...]we agree with Drs. Capodanno and Lip that the burden of evidence favoring the combination VKA + clopidogrel is still limited; on the other hand, we also have to acknowledge the fact that there is not one randomized trial favoring TT. [...]we will have to wait for the results of the large ongoing randomized trials, such as the PIONEER AF (A Study Exploring Two Strategies of Rivaroxaban and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention) and RE-DUAL PCI (Evaluation of Dual Therapy With Dabigatran vs.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.10.061